Related Experiment Video
Updated: Jun 17, 2025

06:07
Measuring Mitochondrial Function of Naïve and Effector CD8 T Cells
Published on: March 28, 2025
221
Targeting mitochondrial damage: shining a new light on immunotherapy.
Wenjuan Zeng1,2, Menghui Wang1,2, Yuxin Zhang3
1Department of Gastrointestinal Surgery, The 2Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China.
Frontiers in Immunology
|August 6, 2024
Summary
Mitochondrial damage worsens cancer by affecting the immune system and tumor microenvironment. Protecting mitochondria or modulating immune cells like macrophages may improve cancer therapy outcomes.
Area of Science:
- Oncology
- Immunology
- Cell Biology
Background:
- Mitochondrial damage significantly impacts cancer progression.
- It disrupts immune cell function and promotes inflammation within the tumor microenvironment.
- Understanding these interactions is crucial for developing effective cancer treatments.
Purpose of the Study:
- To elucidate the intricate relationship between mitochondrial dysfunction, the immune system, and the tumor microenvironment.
- To highlight the potential of targeting mitochondrial integrity and immune cell function for cancer therapy.
Main Methods:
- This study is a review of existing literature.
- It synthesizes current research on mitochondrial dysfunction in cancer immunology.
- Focuses on the interplay between cellular stress, inflammation, and immune response.
Main Results:
- Mitochondrial damage accelerates tumor progression by impairing immune surveillance.
- It triggers inflammatory responses that create a pro-tumorigenic environment.
- Immune cell dysfunction, particularly macrophages, is a key consequence.
Conclusions:
- Preserving mitochondrial integrity is a potential therapeutic strategy.
- Regulating immune cell function, such as that of macrophages, can enhance cancer treatment efficacy.
- Further research into mitochondria-immune system-tumor microenvironment interactions is vital for novel therapeutic development.
More Related Videos
Related Concept Videos
Electron Transport Chain: Complex I and II
12.5K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
12.5K
Tumor Immunotherapy
497
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
497
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K

